MOTS-c

MOTS-c · Hudson Biotech

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MOTS-c, covering 2026-04-01 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity [Phase 2]